Eli Lilly Finalizes Acquisition of Centessa Pharmaceuticals
Pharmaceutical giant Eli Lilly has successfully completed its takeover of Centessa Pharmaceuticals plc. Centessa is a clinical-stage company specializing in developing treatments for narcolepsy and other sleep-wake disorders. This acquisition expands Eli Lilly's pipeline in neurological conditions.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.